Tag Archives: vasomotor
14
Nov
Managing Vasomotor Symptoms with NK3 Receptor Antagonism
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...
14
Nov
Dual NK3/NK1 Receptor Antagonism for Vasomotor Symptoms
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...
07
Nov
Unmet Needs in Managing Vasomotor Symptoms in Menopause
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...
07
Nov
NK Receptor Antagonism as Therapeutic Strategy for Vasomotor Symptoms
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...
31
Oct
Impact of Vasomotor Symptoms on Patient Quality of Life
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...
31
Oct
Pathophysiology of Vasomotor Symptoms in Menopause
This educational roundtable convenes leaders in women’s health to discuss the pathophysiology and qu...
28
Oct
Special Report: Managing vasomotor symptoms in menopause
In the first episode of this 10-part Contemporary OB/GYN Special Report, JoAnn V. Pinkerton, MD, and...
24
Oct
FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms
The FDA has approved elinzanetant 60 mg capsules (Lynkuet; Bayer) for the treatment of moderate to s...
23
Oct
Fezolinetant shows significant real-world improvements in vasomotor symptoms, sleep
Women treated with fezolinetant demonstrated statistically significant improvements in VMS bother re...
28
Jul
Therapies for Vasomotor Symptoms and Their Effects on Bone Mineral Density
Video content above is prompted by the following: Estrogen therapy remains the gold standard for tre...